DNA encoding human colony-stimulating factors

{
  "publication_number": "US5650297A",
  "country": "US",
  "kind": "A",
  "title": "DNA encoding human colony-stimulating factors",
  "abstract": "This invention relates to a biologically active recombinant human M-CSF obtained by expressing a human M-CSF gene coding for the amino acid sequence of the formula (1) in its entirety or devoid of a portion thereof; a process for preparing the recombinant human M-CSF; an expression plasmid containing the human M-CSF gene defined above; and a transformant haboring the above expression plasmid.",
  "claims": [
    "1. A process for preparing a biologically active truncated human macrophage colony stimulating factor (M-CSF) polypeptide comprising: (a) culturing an Escherichia coli host cell transformed with an expression plasmid comprising a DNA encoding a biologically active truncated human M-CSF polypeptide under conditions that allow expression of the encoded polypeptides, wherein said truncated M-CSF polypeptide has a sequence beginning at an amino acid selected from the group consisting of 35 (Val), 36 (Ser) and 37 (Glu) of Formula (I) and ending at amino acid 185 (Thr), inclusive, of Formula (I); and (b) purifying the human M-CSF polypeptide expressed therefrom; ##STR7## wherein X is Tyr or Asp.",
    "2. The process of claim 1 wherein the expression plasmid is selected from the group consisting of pIN-III(lpp P -5)-OmpA-MCSF11-NV151 and pIN-III(lpp P -5)-OmpA-MCSF11-NV143.",
    "3. An Escherichia coli host cell transformed with an expression plasmid comprising a gene encoding a biologically active truncated human macrophage colony stimulating factor (M-CSF) polypeptide, wherein said truncated human M-CSF polypeptide has a sequence beginning at an amino acid selected from the group consisting of 35 (Val), 36 (Ser) and 37 (Glu) of Formula (I) and ending at amino acid 185 (Thr), inclusive, of Formula (I); ##STR8## wherein X is Tyr or Asp.",
    "4. The host cell of claim 3, wherein said expression plasmid is selected from the group consisting of pIN-III(lpp P -5)-OmpA-MCSF11-NV151 and pIN-III(lpp P -5)-OmpA-MCSF11-NV143."
  ],
  "cpc": [
    "C07K 14/53",
    "A61K 38/00"
  ],
  "assignees": [
    "OTSUKA PHARMA CO LTD"
  ],
  "filing_date": "1994-07-27",
  "publication_date": "1997-07-22",
  "grant_date": "1997-07-22",
  "priority_date": "1986-09-17",
  "application_number": "US-28114794-A",
  "family_id": "27571688",
  "citations": [
    "EP0249477A2",
    "EP0261592A1",
    "EP0276551A1",
    "EP0328061A2",
    "EP0410751A2",
    "JPS62169799A",
    "US4675291A",
    "US4677063A",
    "US4847201A",
    "US4868119A",
    "US4879227A",
    "US4929700A",
    "US5026839A",
    "WO8604587A1",
    "WO8604607A1",
    "WO8706954A1",
    "WO8803173A2",
    "WO8808003A1",
    "WO8906546A1"
  ]
}